• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤大小作为结直肠癌预后变量的价值:批判性再评价。

Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal.

机构信息

Department of Surgery, Division of General Surgery, Medical University of Graz, Graz, Austria.

出版信息

Am J Clin Oncol. 2011 Feb;34(1):43-9. doi: 10.1097/COC.0b013e3181cae8dd.

DOI:10.1097/COC.0b013e3181cae8dd
PMID:20101166
Abstract

OBJECTIVES

Vertical tumor growth, reflected by T classification, represents the most important prognostic variable in colorectal cancer. Our study aimed to investigate the impact of tumor size, particularly the maximum tumor diameter, on outcome of affected patients.

METHODS

A total of 381 colorectal cancer specimens were re-evaluated. Tumor size and location were extracted from the medical history and were known for 359 patients (94%). Receiver-operator characteristic analysis was applied to identify the optimal (maximum of sum of sensitivity and specificity) cut-off values with respect to prognostic impact.

RESULTS

Median tumor size was 4.5 cm (range, 0.6-15). Tumor size exceeding 4.5 cm was observed in 159 patients (44%) and was associated with high T and N classification, UICC stage, and tumor grade. At median follow-up of 45 months (range, 0-180), 141 patients (40%) showed tumor progression. Although 4.5 cm was identified as the optimal cut-off value within the whole group of patients, receiver-operator characteristic analysis restricted to different parts of the large bowel determined 5 cm, 5.3 cm, 3.9 cm, and 3.4 cm as cut-off values with the strongest discriminatory capacity in colon, right-sided colon, left-sided colon, and rectum cancers, respectively. Applying these cut-off values, tumor size was significantly associated with progression-free and cancer-specific survival in univariate and multivariate analyses in colon, yet not in rectum cancers.

CONCLUSIONS

Tumor size proved to be an independent prognostic parameter for patients with colorectal cancer. Optimal cut-off values vary among different parts of the large bowel. Whereas prognostic significance is strong within the colon, it appears to be of minor value within the rectum.

摘要

目的

肿瘤纵向生长(T 分类)反映了结直肠癌最重要的预后变量。我们的研究旨在探讨肿瘤大小,特别是最大肿瘤直径,对受影响患者结局的影响。

方法

总共重新评估了 381 例结直肠癌标本。从病史中提取肿瘤大小和位置,359 例患者(94%)已知肿瘤大小和位置。应用受试者工作特征分析确定与预后影响相关的最佳(最大敏感性和特异性之和)截断值。

结果

中位肿瘤大小为 4.5cm(范围 0.6-15cm)。159 例患者(44%)肿瘤大小超过 4.5cm,与高 T 和 N 分类、UICC 分期和肿瘤分级相关。中位随访时间为 45 个月(范围 0-180 个月),141 例(40%)患者出现肿瘤进展。尽管在整个患者组中,4.5cm 被确定为最佳截断值,但在不同部位的大肠中进行的受试者工作特征分析确定,5cm、5.3cm、3.9cm 和 3.4cm 分别为结肠癌、右半结肠癌、左半结肠癌和直肠癌的最佳截断值,具有最强的区分能力。在单因素和多因素分析中,应用这些截断值,肿瘤大小与结肠癌患者的无进展生存期和癌症特异性生存期显著相关,但在直肠癌中则无相关性。

结论

肿瘤大小是结直肠癌患者独立的预后参数。最佳截断值在大肠的不同部位有所不同。在结肠癌中,预后意义较强,而在直肠癌中则意义较小。

相似文献

1
Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal.肿瘤大小作为结直肠癌预后变量的价值:批判性再评价。
Am J Clin Oncol. 2011 Feb;34(1):43-9. doi: 10.1097/COC.0b013e3181cae8dd.
2
Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.预测IV期结直肠癌手术姑息性切除术后生存的因素。
Minerva Chir. 2009 Jun;64(3):303-6.
3
Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.CEA 和 CA19-9 在结直肠癌术后随访中的临床意义。
Ann Surg Oncol. 2010 Sep;17(9):2349-56. doi: 10.1245/s10434-010-1004-5. Epub 2010 Mar 9.
4
Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.结直肠癌缺失蛋白表达作为结直肠癌患者辅助化疗反应的一种可能预测指标。
Dis Colon Rectum. 2004 Jul;47(7):1216-24. doi: 10.1007/s10350-004-0552-9. Epub 2004 May 19.
5
The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.胃肠道癌的多学科管理。分子标志物在结直肠癌诊断和治疗中的应用。
Best Pract Res Clin Gastroenterol. 2007;21(6):1071-87. doi: 10.1016/j.bpg.2007.10.002.
6
[Treatment of colorectal carcinoma].[结直肠癌的治疗]
Orv Hetil. 2003 Oct 26;144(43):2141-2.
7
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.辅助治疗 III 期结直肠癌淋巴结转移患者中 p16 的表达可识别预后不良亚组:匹配原发肿瘤和淋巴结转移的生物标志物的回顾性分析。
Cancer. 2010 Oct 1;116(19):4474-86. doi: 10.1002/cncr.25304.
8
Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.胸苷酸合成酶、胸苷磷酸化酶和二氢叶酸还原酶基因数值异常在结直肠癌中的预后意义。
Acta Oncol. 2008;47(6):1054-61. doi: 10.1080/02841860801942158.
9
[Therapeutic strategies in colorectal cancer].[结直肠癌的治疗策略]
Dtsch Med Wochenschr. 2003 Sep 12;128(37):1902-7. doi: 10.1055/s-2003-42159.
10
Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer.癌胚抗原(CEA)在结直肠癌患者肿瘤组织中的预后价值。
Anticancer Res. 2001 Jul-Aug;21(4B):3031-6.

引用本文的文献

1
A hollow-tube-like hydrospongel for multimodal therapy of advanced colorectal cancer.一种用于晚期结直肠癌多模态治疗的中空管状水凝胶海绵
Nat Commun. 2025 Aug 12;16(1):7464. doi: 10.1038/s41467-025-62880-x.
2
Prediction of 5-year postoperative survival and analysis of key prognostic factors in stage III colorectal cancer patients using novel machine learning algorithms.使用新型机器学习算法预测III期结直肠癌患者术后5年生存率并分析关键预后因素
Front Oncol. 2025 Jul 14;15:1604386. doi: 10.3389/fonc.2025.1604386. eCollection 2025.
3
Risk factors and prediction of distant metastasis (DM) of colon adenocarcinoma: a logistic regression and machine learning study based on surveillance, epidemiology, and end results (SEER) database.
结肠腺癌远处转移(DM)的危险因素及预测:一项基于监测、流行病学和最终结果(SEER)数据库的逻辑回归与机器学习研究
BMC Cancer. 2025 Jul 1;25(1):1047. doi: 10.1186/s12885-025-14329-z.
4
A commentary on "Predicting disease-free survival following curative-intent resection of right-sided colon cancer using a pre-and post-operative nomogram: a prospective observational cohort study".对“使用术前和术后列线图预测右侧结肠癌根治性切除术后无病生存率:一项前瞻性观察队列研究”的述评
Int J Surg. 2025 Sep 1;111(9):6585-6587. doi: 10.1097/JS9.0000000000002760. Epub 2025 Jun 17.
5
Down Expression of Zyxin is Associated with Down Expression of p53 in Colorectal Cancer.结直肠癌中桩蛋白表达下调与p53表达下调相关。
Int J Mol Cell Med. 2025;14(1):461-471. doi: 10.22088/IJMCM.BUMS.14.1.462.
6
Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors.不同种族和族裔群体之间的结直肠癌死亡率差异:社会经济地位、临床病理及治疗相关因素的影响
Cancer Med. 2025 Mar;14(5):e70612. doi: 10.1002/cam4.70612.
7
Augmentation of Solid Tumor Immunotherapy With IL-12.用白细胞介素-12增强实体瘤免疫疗法
J Gene Med. 2024 Dec;26(12):e70000. doi: 10.1002/jgm.70000.
8
Effects of the Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls score on postoperative clinical outcomes following colorectal cancer surgery: a retrospective study.结直肠癌手术后力量、步行辅助、从椅子上起身、爬楼梯及跌倒评分对术后临床结局的影响:一项回顾性研究
Eur J Clin Nutr. 2025 Apr;79(4):358-364. doi: 10.1038/s41430-024-01509-6. Epub 2024 Oct 24.
9
Association between tumor size and prognosis in patients with small bowel adenocarcinoma-a SEER-based study.小肠腺癌患者肿瘤大小与预后的关系——一项基于监测、流行病学和最终结果(SEER)数据库的研究
Heliyon. 2024 Aug 30;10(17):e36881. doi: 10.1016/j.heliyon.2024.e36881. eCollection 2024 Sep 15.
10
Sexual dimorphism of colorectal cancer in humans and colorectal tumors in a murine model.人类结直肠癌及小鼠模型中结直肠肿瘤的性别二态性。
Front Oncol. 2024 Aug 6;14:1398175. doi: 10.3389/fonc.2024.1398175. eCollection 2024.